FDA Keeps Brand-Name Drugs On A Fast Path To Market ― Despite Manufacturing Concerns
By Sydney Lupkin
The agency approved Gilead’s “game changer” hepatitis C cure, bypassing concerns raised by its own federal inspectors. The problems they found at the company’s main U.S. drug-testing laboratory in Foster City, Calif., were so bad, they recommended withholding approval.